Queen Square Courses
- Neurology 2015: leading edge neurology for the practising clinician - 25-27 March 2015
- 14th Annual Course: Neuroradiology & Functional Neuroanatomy - FULLY BOOKED
- Statistical Parametric Mapping Short Courses
- MRCP PACES Neurology Course Queen Square
- International Cerebral Amyloid Angiopathy Meeting
- Statistical Parametric Mapping short courses
- Update in neuromuscular disorders 2014
- Masterclass on Sexual Dysfunction in Neurological Disorders
Published: Jan 16, 2014 12:32:49 PM
Published: May 11, 2013 3:39:00 PM
Published: Aug 12, 2014 1:23:13 PM
Published: Sep 16, 2013 1:37:21 PM
Published: Dec 10, 2013 2:49:43 PM
Published: Jul 30, 2014 4:41:41 PM
International Cerebral Amyloid Angiopathy Meeting
Publication date: Jan 16, 2014 12:32:49 PM
Sep 18, 2014 12:00:00 AM
End: Sep 20, 2014 12:00:00 AM
Location: Basement Lecture Theatre, 33 Queen Square
Date: September 18th-20th 2014
Venue: 33 Queen Square, London, WC1N 3BG
This conference is organised by the International CAA Association and Dr David Werring, UCL Institute of Neurology
Queen Square is recognized worldwide as a unique centre of excellence in clinical neurology and neurosciences research. Its long and rich heritage dates back to the foundation of the National Hospital in 1859. Researchers from Queen Square have made major contributions to themes underpinning our understanding of cerebral amyloid angiopathy, including the amyloid hypothesis of Alzheimers disease, hereditary forms of Alzheimer’s disease, and the specific genetic form of cerebral amyloid angiopathy, Familial British Dementia.
The conference goals will be to bring together the leading international experts in ß-amyloid metabolism, vascular biology, neuropathology, circulating biomarkers, stroke genetics, brain imaging, and the clinical manifestations of cerebrovascular disease to present and discuss cutting-edge data in this rapidly developing field. The conference will aim to authoritatively summarize the state-of-the art in these key aspects of CAA research and to move the field towards identification of disease-modifying therapies.
Anticipated key themes will include: biomarkers for early detection and monitoring disease activity or progression; mechanisms of vascular amyloid accumulation; progress in discovery and testing of candidate disease-modifying biological treatments for CAA; and how CAA interacts with and contributes to Alzheimer’s disease.
An overarching goal will be the development of international networks to investigate CAA in large-scale studies. The atmosphere for discussion is anticipated to be interactive, informal, and lively, with extensive opportunities for forming new collaborations and relationships within the growing CAA scientific and clinical communities.
To book a place on to this course please visit the International CAA Association website
Page last modified on 16 jan 14 12:09